Streetbeat News

Stock Prices

PRTC

PureTech Health shares declined following the announcement of a year-over-year decrease in their H1 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 2:23 pm

OOMA

Ooma shares rose after the company reported better-than-expected Q2 financial results and increased its FY25 revenue and Q3 guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 2:22 pm

SABS

SAB Biotherapeutics shares rose following Oppenheimer's initiation of coverage with an Outperform rating and a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 2:19 pm

AVAV

BOX

KSS

WALD

Kohl's Corporation reported better-than-expected Q2 earnings, leading to a 5.6% rise in its stock price. Other companies like Waldencast, AeroVironment, and Box also saw significant gains due to positive earnings reports and analyst upgrades.

Portfolio Pulse from Avi Kapoor

August 28, 2024 | 2:17 pm

JPM

The article highlights a surge in options activity for JPMorgan Chase (NYSE:JPM), with a notable bearish sentiment among traders. Analysis shows a mix of bullish and bearish trades, with a focus on a price range of $135 to $240. The stock is currently trading at $221.5, with a slight increase of 0.6%. An analyst from Morgan Stanley maintains an Overweight rating with a target price of $226.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 2:16 pm

FCX

Freeport-McMoRan has seen unusual options activity with a bullish sentiment from large investors. 66% of the trades were bullish, focusing on a price range of $39 to $60. The stock is currently trading at $43.99, down 2.73%, with a neutral RSI. Analysts have a target price of $52.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 2:16 pm

PLTR

Recent options activity for Palantir Technologies (NYSE:PLTR) shows a bearish sentiment among financial giants, with 55% of trades being bearish. The stock is currently down 1.74% at $30.3, and analysts have mixed ratings with price targets ranging from $9 to $30. Options trading indicates a targeted price range of $21 to $33.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 2:16 pm

TGT

This week in investing, key topics include uranium production cuts by Kazatomprom, significant job data revisions in the U.S., political proposals for taxing unrealized capital gains, a rise in gold prices, and Target's earnings report. Kazatomprom's production cuts amidst rising demand suggest a potential increase in uranium prices. The U.S. job market saw a major downward revision, raising concerns about economic strength. Political proposals for taxing unrealized gains could disrupt investment strategies. Gold prices hit a new high as the Fed signals rate cuts. Target's earnings beat estimates, but future growth guidance is lowered.

Portfolio Pulse from Gary Brode

August 28, 2024 | 2:15 pm

MTEK

Maris-Tech shares rose following the announcement of better-than-expected H1 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 2:15 pm

VRAX

Virax Biolabs Group Limited (NASDAQ:VRAX) stock surged 30.3% after announcing a distribution agreement for RT-PCR Mpox detection kits in 13 European countries and the Gulf Cooperation Council. The kits have high sensitivity and specificity rates, providing results in under 70 minutes.

Portfolio Pulse from Dylan Berman

August 28, 2024 | 2:14 pm